Fulton Breakefield Broenniman LLC Abb Vie Inc. Transaction History

Fulton Breakefield Broenniman LLC

$1.41 Billion
Q3 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 90,764 shares of ABBV stock, worth $15 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

90,764

Previous 94,494 3.95%

Holding current value

$15 Million

Previous $16.2 Million 10.59%

% of portfolio

1.27%

Previous 1.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $611,123 - $743,500	-3,730 Reduced 3.95%	90,764 $17.9 Million
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $194,880 - $227,576	-1,259 Reduced 1.31%	94,494 $16.2 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $199,775 - $227,625	-1,250 Reduced 1.29%	95,753 $17.4 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $74,441 - $83,838	-541 Reduced 0.55%	97,003 $15 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $78,283 - $90,624	586 Added 0.6%	97,544 $14.5 Million
Q2 2023 Jul 19, 2023	BUY	$132.51 - $164.9 $305,833 - $380,589	2,308 Added 2.44%	96,958 $13.1 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $168,904 - $194,518	1,168 Added 1.25%	94,650 $15.1 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $300,685 - $360,601	2,174 Added 2.38%	93,482 $15.1 Million
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $37,847 - $43,408	-282 Reduced 0.31%	91,308 $12.3 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $138,032 - $175,484	-1,003 Reduced 1.08%	91,590 $14 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $2.35 Million - $2.91 Million	17,785 Added 23.77%	92,593 $15 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $71,333 - $90,257	-664 Reduced 0.88%	74,808 $10.1 Million
Q3 2021 Oct 25, 2021	BUY	$106.4 - $120.78 $11,597 - $13,165	109 Added 0.14%	75,472 $8.14 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $190,009 - $211,681	1,806 Added 2.46%	75,363 $8.49 Million
Q1 2021 Apr 09, 2021	BUY	$102.3 - $112.62 $1.23 Million - $1.35 Million	12,007 Added 19.51%	73,557 $7.96 Million
Q4 2020 Jan 14, 2021	BUY	$80.49 - $108.67 $4.62 Million - $6.24 Million	57,414 Added 1388.15%	61,550 $6.6 Million
Q2 2020 Jul 10, 2020	SELL	$73.37 - $98.18 $24,138 - $32,301	-329 Reduced 7.37%	4,136 $406,000
Q1 2020 Apr 10, 2020	SELL	$64.5 - $97.79 $42,763 - $64,834	-663 Reduced 12.93%	4,465 $340,000
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $49,697 - $62,182	689 Added 15.52%	5,128 $454,000
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $279,568 - $336,121	4,439 New	4,439 $336,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Abb Vie Inc. Transaction History